TickerFacts.

NRX Pharmaceuticals, Inc. (NRXP): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$9.16M
As of 2023-12-31
$10.53M2022-12-31: $10.53M2023-12-31: $9.16M$9.16M
2022-12-31 Long-Term Debt (USD) 2023-12-31
Period endedLong-Term DebtChange YoYSource filing
2023-12-31$9.16M-13.0%2024-03-29, Balance as of period end
2022-12-31$10.53Mn/a2024-03-29, Balance as of period end